FR2854399B1 - 1-aryl-3-(indol-5-yl)-prop-2-en-1-ones, compositions les contenant et utilisation - Google Patents

1-aryl-3-(indol-5-yl)-prop-2-en-1-ones, compositions les contenant et utilisation

Info

Publication number
FR2854399B1
FR2854399B1 FR0305389A FR0305389A FR2854399B1 FR 2854399 B1 FR2854399 B1 FR 2854399B1 FR 0305389 A FR0305389 A FR 0305389A FR 0305389 A FR0305389 A FR 0305389A FR 2854399 B1 FR2854399 B1 FR 2854399B1
Authority
FR
France
Prior art keywords
indol
prop
aryl
ones
compositions containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR0305389A
Other languages
English (en)
Other versions
FR2854399A1 (fr
Inventor
Patrick Mailliet
Fabienne Thompson
Luc Bertin
Gerard Leclere
Gilles Tiraboschi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Priority to FR0305389A priority Critical patent/FR2854399B1/fr
Priority to PCT/FR2004/001012 priority patent/WO2004099193A2/fr
Priority to JP2006505814A priority patent/JP2006525291A/ja
Priority to EP04742579A priority patent/EP1622895A2/fr
Priority to US10/835,631 priority patent/US20040229931A1/en
Publication of FR2854399A1 publication Critical patent/FR2854399A1/fr
Application granted granted Critical
Publication of FR2854399B1 publication Critical patent/FR2854399B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FR0305389A 2003-04-30 2003-04-30 1-aryl-3-(indol-5-yl)-prop-2-en-1-ones, compositions les contenant et utilisation Expired - Lifetime FR2854399B1 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
FR0305389A FR2854399B1 (fr) 2003-04-30 2003-04-30 1-aryl-3-(indol-5-yl)-prop-2-en-1-ones, compositions les contenant et utilisation
PCT/FR2004/001012 WO2004099193A2 (fr) 2003-04-30 2004-04-27 1-aryl-3-(indol-5-yl)-prop-2-en-1-ones, compositions les contenant et utilisation
JP2006505814A JP2006525291A (ja) 2003-04-30 2004-04-27 １−アリール−３−（インドール−５−イル）プロパ−２−エン−１−オン、該化合物を含む組成物、及びそれらの使用
EP04742579A EP1622895A2 (fr) 2003-04-30 2004-04-27 1-aryl-3-(indol-5-yl)-prop-2-en-1-ones, compositions les contenant et utilisation
US10/835,631 US20040229931A1 (en) 2003-04-30 2004-04-30 1-Aryl-3-(indol-5-yl) prop-2-en-1-ones, compositions containing them and use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0305389A FR2854399B1 (fr) 2003-04-30 2003-04-30 1-aryl-3-(indol-5-yl)-prop-2-en-1-ones, compositions les contenant et utilisation

Publications (2)

Publication Number Publication Date
FR2854399A1 FR2854399A1 (fr) 2004-11-05
FR2854399B1 true FR2854399B1 (fr) 2006-11-17

Family

ID=33155601

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0305389A Expired - Lifetime FR2854399B1 (fr) 2003-04-30 2003-04-30 1-aryl-3-(indol-5-yl)-prop-2-en-1-ones, compositions les contenant et utilisation

Country Status (4)

Country Link
EP (1) EP1622895A2 (fr)
JP (1) JP2006525291A (fr)
FR (1) FR2854399B1 (fr)
WO (1) WO2004099193A2 (fr)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0680950B1 (fr) * 1993-11-17 2001-05-23 Kyowa Hakko Kogyo Co., Ltd. Derives de propenone
CA2193666A1 (fr) * 1995-05-10 1996-11-14 Shun-Ichi Ikeda Derives de propenone
PE20030758A1 (es) * 2001-12-05 2003-10-07 Aventis Pharma Sa 1,3-diarilprop-2-en-1-onas, composiciones que las contienen y su utilizacion

Also Published As

Publication number Publication date
WO2004099193A3 (fr) 2005-01-06
FR2854399A1 (fr) 2004-11-05
JP2006525291A (ja) 2006-11-09
WO2004099193A2 (fr) 2004-11-18
EP1622895A2 (fr) 2006-02-08

Similar Documents

Publication Publication Date Title
FR15C0037I2 (fr) Compositions monodisperses contenant du naloxol pegyle
FR2885904B1 (fr) Nouveaux derives du fluorene, compositions les contenant et utilisation
MA29030B1 (fr) 2-alcoxy-3,4,5-trihydroxy-alkylamides, leur preparation, compositions les contenant et utilisation
NL1025404A1 (nl) Pyrazolo-triazine verbindingen en gebruik daarvan.
MA28512B1 (fr) Derive heterocyclique accole, composition medicamenteuse en contenant, et son utilisation medicamenteuse
DE60325255D1 (de) Duftzusammensetzung
FR2843023B1 (fr) Compositions cosmetiques ou dermopharmaceutiques contenant du kombucha.
FR2848115B1 (fr) Composition de bacteries et son utilisation
NO20053974D0 (no) Tienopyrimidinforbindelser og anvendelse derav.
EP1626717A4 (fr) Benzimidazoles, compositions contenant lesdits composes et methodes d'utilisation
FR2862654B1 (fr) Composition amylacee filmogene
SE0500163L (sv) Sammansättning
DK1670769T3 (da) Benzimidazol-derivater, sammensætninger indeholdende disse, fremstilling deraf og anvendelser deraf
FR2903406B1 (fr) Derives de pyrazolylbenzimidazole,compositions les contenant et utilisation
DE602004026410D1 (de) Syndiotaktisches propylenpolymer enthaltende zusammensetzung
FR2857363B1 (fr) 4,5,6,7-tetrahydro-1h-pyrazolo[3,4-c] pyridines substituees compositions les contenant et utilisation
FR2855825B1 (fr) Produits aryl-heteroaromatiques, compositions les contenant et utilisation
FR2854399B1 (fr) 1-aryl-3-(indol-5-yl)-prop-2-en-1-ones, compositions les contenant et utilisation
EP1696952A4 (fr) Agents antiretroviraux, compositions et methodes d'utilisation
MA27351A1 (fr) 1,3-diarylprop-2-en-1-ones, compositions les contenant et utilisation
FR2901554B1 (fr) 2-alcoxy-3,4,5-trihydroxy-alkylamide-benzazepine, leur preparation, compositions les contenant et utilisation
FR2835431B1 (fr) COMPOSITION COSMETIQUE CONTENANT UNE Nx,Ng-DIACYLARGININE
FR2833004B1 (fr) Aryl-cycloalcaines substitues, compositions les contenant et utilisation
DK1680134T3 (da) Sammensætninger og anvendelser deraf
ITTO20040104A1 (it) Composizione pesticida